Jim Wilgus, Executive Director for the Washington State Chapter of the Alzheimer's Association, joins Suzanne Newman on the Answers for Elders Radio Show to talk about the need for participants in Alzheimer's clinical trials.Jim says, "There are circumstances, certainly, where Alzheimer's disease is prevalent within family units, but there's also incidents where it's not. And that's what makes Alzheimer's disease such a mystery, and why research and clinical trials are so important. There's also known evidence that Alzheimer's disease and other dementia are more prevalent in certain populations, particularly African Americans and Hispanic Americans."There are needs for all kinds of individuals. And certainly some trials don't require a diagnosis, some trials do. But the bottom line is we need participants in trials. They're safe, they're ethically sound and founded. Many of them are at universities and hospitals, and new treatments for Alzheimer's disease and other dementia are nearly impossible without clinical trials. Many more participants are needed, including people, as I mentioned, with dementia or those who are at risk of developing it. Also, for caregivers, or healthy volunteers, with no dementia issues. All are urgently needed for the hundreds and hundreds of trials that take place throughout the United States."Visit https://www.alz.org/trialmatch to find clinical trials in your area.Alzheimer's Association websiteAbout Alzheimer's and DementiaCall their helpline at 800.272.3900Hear more podcasts about the Alzheimer's AssociationHear more podcasts about the Walk to End AlzheimersCheck out our affiliate podcast Alzheimer’s Speaks

Ver todos los episodios